1 ANNEX, Regulation (EU) 2020/484

In forcesince 30 Aug 2021

The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:

(1)

in Table 1 (Authorised novel foods), the following entry is inserted in alphabetical order:

Authorised novel food | Conditions under which the novel food may be used | Additional specific labelling requirements | Other requirements | Data Protection

‘Lacto-N-tetraose (“LNT”)

(microbial source)

Specified food category | Maximum levels |

The designation of the novel food on the labelling of the foodstuffs containing it shall be “lacto-N-tetraose”.

The labelling of food supplements containing lacto-N-tetraose shall bear a statement that they should not be used if breast milk or other foods containing added lacto-N-tetraose are consumed the same day.

Authorised on 23.4.2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food lacto-N-tetraose is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 23.4.2025.’

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 1,0 g/l

Unflavoured fermented milk-based products |

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products |

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Beverages (flavoured drinks) | 1,0 g/l

Cereal bars | 10 g/kg

Infant formula as defined under Regulation (EU) No 609/2013 | 0,8 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013 | 0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food, baby food for infants and young children as defined under Regulation (EU) No 609/2013 |

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Milk based drinks and similar products intended for young children |

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 |

2,0 g/l (beverages)

20 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, excluding infants | 2,0 g/day for young children, children, adolescents, and adults

(2)

in Table 2 (Specifications), the following entry is inserted in alphabetical order:

CFU: Colony Forming Units.’

Authorised Novel Food | Specification

‘Lacto-N-tetraose (“LNT”) (microbial source) |

Definition:

Chemical formula: C26H45NO21

Chemical name: β-D-Galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-D-glucopyranose

Molecular mass: 707.63 Da

CAS No 14116-68-8

Description:

Lacto-N-tetraose is a purified, white to off-white amorphous powder or agglomerates that is produced by a microbial process.

Source:

Genetically modified strain of Escherichia coli strain K-12 DH1

Characteristics/Composition:

Appearance: White to off white powder or agglomerates

Sum of lacto-N-tetraose, D-Lactose and lacto-N-triose II (% of dry matter): ≥ 90.0 % (w/w)

Lacto-N-tetraose (% of dry matter): ≥ 70.0 % (w/w)

D-Lactose: ≤ 12.0 % (w/w)

Lacto-N-triose II: ≤ 10.0 % (w/w)

Para-lacto-N-hexaose-2: ≤ 3.5 % (w/w)

Lacto-N-tetraose fructose isomer: ≤ 1.0 % (w/w)

Sum of other carbohydrates: ≤ 5.0 % (w/w)

Moisture: ≤ 6.0 % (w/w)

Ash, sulfated: ≤ 0.5 % (w/w)

pH (20 °C, 5 % solution): 4.0 -6.0

Residual protein: ≤ 0.01 % (w/w)

Microbiological criteria:

Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g

Enterobacteriaceae: ≤ 10 CFU/g

Salmonella spp.: Negative/25 g

Yeast: ≤ 100 CFU/g

Mould: ≤ 100 CFU/g

Residual endotoxins: ≤ 10 EU/mg